Sernova Corp. (TSE:SVA – Get Free Report)’s share price crossed above its fifty day moving average during trading on Tuesday. The stock has a fifty day moving average of C$0.11 and traded as high as C$0.12. Sernova shares last traded at C$0.12, with a volume of 149,829 shares traded.
Sernova Stock Performance
The stock has a market capitalization of C$43.43 million, a P/E ratio of -1.64 and a beta of -0.49. The company has a current ratio of 0.03, a quick ratio of 18.11 and a debt-to-equity ratio of -21.98. The company has a 50-day moving average price of C$0.11 and a two-hundred day moving average price of C$0.14.
Sernova (TSE:SVA – Get Free Report) last announced its earnings results on Thursday, September 10th. The company reported C($0.01) EPS for the quarter. On average, equities analysts forecast that Sernova Corp. will post -0.08 earnings per share for the current year.
About Sernova
Sernova Biotherapeutics is a clinical-stage company developing regenerative medicine therapeutics combining its Cell Pouch with human donor cells or stem-cell derived islet-like clusters in collaboration with Evotec to create bio-hybrid organs to treat T1D. A bio-hybrid organ is comprised of non-biomaterials, such as the Cell Pouch, integrated with living tissues to restore or enhance the function of a compromised organ. This innovative approach aims to deliver a potentially revolutionary treatment for patients with chronic diseases, initially focusing on T1D and thyroid disorders.
Featured Articles
- Five stocks we like better than Sernova
- Marriott’s Earnings Beat Shows Why It’s More Than a Bet on Travel Demand
- Franklin Templeton’s New ETFs Turn Stock Dividends Into Bitcoin—What’s the Catch?
- Apple’s Earnings Beat Comes With a Catch for Investors Heading Into the Holidays
- Palantir’s $2.3 Billion Quarter Puts Its Premium Valuation to the Test
Receive News & Ratings for Sernova Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Sernova and related companies with MarketBeat.com's FREE daily email newsletter.
